h-hydrogen

Background: Tender plasma MRNA encoded by the PLAC4 gene (placenta-specific 4), which is transcribed from chromosome 21 in placental cells, is a capability marker for the noninvasive assessment of chromosome 21 dosage in the fetus. We evaluated the diagnostic sensitivities and specificities of 2 trisomy 21–screening approaches that use kind plasma PLAC4 MRNA.

Methods: We contrived tender plasma samples from 153 replete women carrying euploid and trisomy 21 fetuses. For the samples in which the fetuses were heterozygous for the wilful PLAC4 single-nucleotide polymorphism (SNP), we regulated the correlation agent 2 alleles of the SNP in caring plasma PLAC4 MRNA (RNA-SNP) by numbers spectrometric (MS) and digital PCR methods. For pregnancies involving fetuses homozygous for the SNP, we quantified the aggregate PLAC4 MRNA concentration in nurturing plasma by real-time PCR and digital PCR.

Results: For the RNA-SNP approach, we achieved a diagnostic understanding and specificity of 100% (95% CI, 40.2%–100%) and 89.7% (95% CI, 78.8%–96.1%), respectively, for both the MS and the digital PCR methods. For the mRNA-quantification approach, the areas tipsy the ROC curves were 0.859 (95% CI, 0.741–0.903) and 0.833 (95% CI, 0.770–0.923) for plasma PLAC4 MRNA concentrations quantified by the real-time PCR and the digital PCR methods, severally.

Conclusions: For prenatal screening of trisomy 21, the quantification of the unqualified PLAC4 MRNA concentration can be inured to in a synergistic means with the RNA-SNP allelic correspondence solicit to addition the citizenry coverage of cases in which diagnostic facts can be obtained.